Lateral thinking: Lateral flow test engineering and lessons learned from COVID-19
Many of our i-sense team members have received awards or fellowships over the past year - let’s take a closer look at a few of our award updates.
Zyme Biosciences, a team led by Dr Marta Broto Aviles who is an i-sense postdoc in Prof Molly Stevens group at Imperial College London, have made the finals of WE Innovate 2021. The scheme is led by the Imperial Enterprise Lab and provides a platform to showcase the incredible progress being made in women’s entrepreneurship at Imperial – with winning teams receiving a part of a 30K prize fund for their ideas.
The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV, according to a study led by researchers in the i-sense McKendry group at UCL.
Professor Molly Stevens’ team have been awarded £50,000 in funding from the new Imperial College COVID-19 Response Fund to develop point-of-care diagnostics for the current pandemic.
A simple and sensitive test developed by i-sense engineers at Imperial College London, in collaboration with MIT, has produced a colour change in urine to signal growing tumours in mice.
i-sense researchers are developing a new way to rapidly detect genetic barcodes for tuberculosis in the blood.
i-sense researchers are developing a new way to rapidly detect genetic barcodes for tuberculosis in the blood.
The successful treatment and cure of all diseases relies heavily on accurate diagnosis: if we don’t know what a disease is, we won’t know how to stop it. The ramifications of this can be very serious, with delays in diagnosis and treatment playing a key factor in many deaths and dehabilitating conditions. Traditional diagnostic tools and procedures have been used to great effect in many cases, but they do have limitations.
